Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Fatigue, Cardiovascular Declin...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Fatigue, Cardiovascular Decline, and Events after Breast Cancer Treatment

Bibliographic Details
Published in:JACC. CardioOncology
Main Authors: Jennifer H. Jordan, PhD, MS, Ralph B. D’Agostino, Jr., PhD, Nancy E. Avis, PhD, Shannon L. Mihalko, PhD, Peter H. Brubaker, PhD, Dalane Kitzman, MD, Karen M. Winkfield, MD, PhD, Cynthia K. Suerkin, MS, Kerryn W. Reding, PhD, MPH, RN, Heidi D. Klepin, MD, MS, Glenn J. Lesser, MD, W. Gregory Hundley, MD
Format: Article
Language:English
Published: Elsevier 2020-03-01
Online Access:http://www.sciencedirect.com/science/article/pii/S2666087320300223
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2666087320300223

Similar Items

  • Dietary Interventions in Heart Failure With Preserved Ejection Fraction
    by: Hayley E. Billingsley, PhD, RDN, et al.
    Published: (2025-01-01)
  • Assessment of effectiveness and safety of thrombolytic therapy to pulmonary emboli by endobronchial ultrasound-guided transbronchial needle injectionCentral MessagePerspective
    by: Yuki Sata, MD, PhD, et al.
    Published: (2023-12-01)
  • J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan
    by: Eisaku Miyauchi, MD, PhD, et al.
    Published: (2025-03-01)
  • Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy
    by: Junko Tanizaki, MD, PhD, et al.
    Published: (2023-12-01)
  • COVID-19 vaccine-induced Recurrence of the Radiation Recall Phenomenon in the Laryngeal Mucosa Due to a VEGF Inhibitor
    by: Shotaro Tatekawa, MD, PhD, et al.
    Published: (2022-11-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs